Article Details

Jazz Pharma to buy GW Pharma for $7.2 bln, adding cannabis-based drug to portfolio

Retrieved on: 2021-02-03 17:37:30

Tags for this article:

Click the tags to see associated articles and topics

Jazz Pharma to buy GW Pharma for $7.2 bln, adding cannabis-based drug to portfolio. View article details on hiswai:

Excerpt

The deal took some cannabis-focused exchange-traded funds (ETFs) by surprise. Many saw it as a seal of approval for the medical marijuana industry ...

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo